Profiles of healing and nonhealing Cryptosporidium parrum infection in C57BL/6 mice with functional B and T lymphocytes: The extent of gamma interferon modulation determines the outcome of infection

Infection and Immunity

Volumn 65, Issue 11, 1997, Pages 4761-4769

  Theodos, Cynthia M ^a   Sullivan, Kristen L ^a,e   Griffiths, Jeffrey K ^a,b,c   Tzipori, Saul ^a,d  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; INFECTION PREVENTION; INTRAPERITONEAL DRUG ADMINISTRATION; MESENTERY LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030817862     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.11.4761-4769.1997     Document Type: Article

References (69)

1. Aguirre, S. A., P. H. Mason, and L. E. Perryman. 1994. Susceptibility of major histocompatibility complex (MHC) class I- and class II-deficient mice to Cryptospondium parvum infection. Infect. Immun. 62:697-699.
2. Amiri, P., M. Haak-Frendscho, K. Robbins, J. H. McKerrow, T. Stewart, and P. Jardieu. 1994. Anti-immunoglobulin E. treatment decreases worm burden and egg production in Schistosoma mansoni infected normal and interferon gamma knockout mice. J. Exp. Mod. 180:43-51.
3. Arrowood, M. J., J. R. Mead, J. L. Mahr, and C. R. Sterling, 1989. Effects of immune colostrum and orally administered antisporozoite monoclonal antibodies on the outcome of Cryptosporidium parvum infections in neonatal mice. Infect. Immun. 57:2283-2288.
4. Bjorneby, J. M., B. D. Hunsaker, M. W. Riggs, and L. E. Perryman. 1991. Monoclonal antibody immunotherapy in nude mice persistently infected with Cryptosporidium parvum. Infect. Immun. 59:1172-1176.
5. Black, B. E., K. H. Brown, and S. Becker. 1984. Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics 173:799-805.
6. Bouley, D. M., S. Kanagat, W. Wire, and B. T. Rouse. 1995 Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-γ knockout mice. J. Immunol. 155:3904-3971.
7. Campbell, P. N., and W. L. Current. 1983. Demonstration of serum antibodies to Cryptosporidium sp. in normal and immunodeficient humans with confirmed infection. J. Clin. Microbiol 18:165-169.
8. Chakkalath, H. R., C. M. Theodos, J. S. Markowitz, M. J. Grusby, L. H. Glimcher, and R. G. Titus. 1995. Class II major histocompatibility complex-deficient mice initially control an infection with L. major but succumb to the disease. J. Infect. Dis. 171:1302-1308.
9. Chen, W., J. A. Harp, A. G. Harmsen, and E. A. Havell. 1993. Gamma interferon functions in resistance to Cryptosporidium infection in severe combined immunodeficient mice. Infect. Immun. 61:3548-3551.
10. Chen, W., J. A. Harp, and A. Harmsen. 1993. Requirements for CD4 cells and gamma interferon in resolution of established Cryptosporidium purvum infection in mice. Infect. Immun. 61:3928-3932.
11. Cheng, L., K. R. Rasmussen, M. Healey, and S. Yang. 1996. Primary and secondary infections with Cryptosporidium parvum in immunosuppressed adult mice. Am. J. Trop. Med. Hyg. 55:324-329.
12. 11a.Coffman, R. Personal communication.
13. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferonγ gene-disrupted mice. J. Exp. Med. 178:2243-2247.
14. Current, W. L., and B. L. Blagburn. 1991. Cryptosporidium and microsporidia: some closing comments. J. Protozool. 38:244S-245S.
15. Current, W. L., and L. S. Garcia. 1991. Cryptosporidiosis. Clin. Microbiol. Rev. 4:325-358.
16. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259:1739-1742.
17. Doyle, P. S., J. Crabb, and C. Petersen. 1993. Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect. Immun. 61:4079-4084.
18. Enriquez, F. J., and C. R. Sterling. 1991. Cryptosporidium infections in inbred strains of mice. J. Protozool. 38:100S-102S.
19. Ernest, J. A., B. L. Blagburn, D. S. Lindsay, and W. L. Current. 1986. Infection dynamics of Cryptosporidium parvum (Apicomplexa: Cryptosporidiae) in neonatal mice (Mus musculus). J. Parasitol. 72:796-798.
20. Flynn, J. L., M. M. Goldstein, K. J. Triebold, J. Sypek, S. Wolf, and B. R. Bloom. 1995. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 155:7515-2524.
21. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferonγ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
22. Graham, M. B., D. K. Dalton, D. Giltinan, V. L. Braciale, T. A. Stewart, and T. J. Braciale. 1993. Response to influenza infection in mice with a targeted disruption in the interferon γ gene. J. Exp. Med. 178:1725-1732.
23. + T cells in response to Cryptosporidium parvum antigen. J. Parasitol. 80:67-72.
24. Harp, J. A., and R. E. Sacco. 1996. Development of cellular immune functions in neonatal to weanling mice: relationship to Cryptosporidium parvum infection. J. Parasitol. 82:245-249.
25. Harty, J. T., and M. J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFNγ. Immunity 3:109-117.
26. Heine, J. H., W. Moon, and D. B. Woodmansee. 1984. Persistent Cryptosporidium infection in congenitally athymic nude mice. Infect. Immun. 43:856-859.
27. Kassa, M., E. Comby, D. Lemeteil, P. Brasseur, and J.-J. Ballet. 1991. Characterization of anti-Cryptosporidium IgA antibodies in sera from immunocompetent individuals and HIV-infected patients. J. Protozool. 38:179S-180S.
28. Koster, K. F., C. G. Curlin, K. M. Aziz, and A. Haque. 1981. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bull. W. H. O. 59:901-908.
29. Kuhls, T. L., D. A. Mosier, V. L. Abrams, D. L. Crawford, and R. A. Greenfield. 1994. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency. J. Parasitol. 80:480-485.
30. McDonald, V., R. Deer, S. Uni, M. Iseki, and G. J. Bancroft. 1992. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect. Immun. 60:3325-3331.
31. McDonald, V., and G. Bancroft. 1994. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol. 16:315-320.
32. Mead, J. R., M. J. Arrowood, and C. Sterling. 1988. Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans. J. Parasitol. 74:135-143.
33. Mead, J. R., M. J. Arrowood, R. W. Sidwell, and M. C. Healey. 1991. Chronic Cryptosporidium parvum infections in congenitally immunodeficient SCID and nude mice. J. Infect. Dis. 163:1297-1304.
34. Mead, J. R., N. Ilksoy, X. You, Y. Belenkaya, M. Arrowood, M. T. Fallon, and R. Schinazi. 1994. Infection dynamics and clinical features of cryptosporidiosis in SCID mice. Infect. Immun. 62:1691-1695.
35. Mead, J. R., M. J. Arrowood, M. C. Healey, and R. W. Sidwell. 1991 Cryptosporidial infections in SCID mice reconstituted with human or murine lymphocytes. J. Protozool. 38:59S-61S.
36. Moss, D. M., and P. J. Lammie. 1993. Proliferative responses of lymphocytes from Cryptosporidium parvum-exposed mice to two separate antigen fractions from oocysts. Am. J. Trop. Med. Hyg. 49:393-401.
37. Nord, J., P. Ma, D. DiJohn, S. Tzipori, and C. O. Tacket. 1990. Treatment with bovine hyperimmune colostrum of Cryptosporidial diarrhea in AIDS patients. AIDS 4:581-584.
38. Ortega-Mora, L. M., J. M. Troncoso, F. A. Rojo-Vazquez, and M. Gomez-Bautista. 1993. Serum antibody response in lambs naturally and experimentally infected with Cryptosporidium parvum. Vet. Parasitol. 50:45-54.
39. Ortega-Mora, L. M., J. M. Troncoso, F. A. Rojo-Vazquez, and M. Gomez-Bautista. 1994. Identification of Cryptosporidium parvum oocyst/sporozoite antigens recognized by infected and hyperimmune lambs. Vet. Parasitol. 53:159-166.
40. Peeters, J. E., I. Villacorta, E. Vanopdenbosch, D. Vandergheynst, M. Naciri, E. Ares-Mazás, and P. Yvoré. 1992. Cryptosporidium parvum in calves: kinetics and immunoblot analysis of specific serum and local antibody responses (immunoglobulin A |IgA], IgG. and IgM) after natural and experimental infections. Infect. Immun. 60:2309-2316.
41. Perryman, L. E., P. A. Mason, and C. E. Chrisp. 1994. Effect of spleen cell populations on resolution of Cryptosporidium parvum infection in SCID mice. Infect. Immun. 62:1474-1477.
42. Perryman, L. E., and J. M. Bjorneby. 1991. Immunotherapy of cryptosporidiosis in immunodeficient animal models. J. Protozool. 38:98S-100S.
43. Petersen, C. 1992. Cryptosporidiosis in patients infected with the human immunodeficiency virus. Clin. Infect. Dis 15:903-909.
44. Reperant, J. M., M. Naciri, S. lochmann, M. Tilley, and D. Bout. 1994 Major antigens of Cryptosporidium parvum recognized by serum antibodies from different infected animal species and man. Vet. Parasitol. 55:1-13.
45. Reperant, J.-M., M. Naciri, T. Chardes, and D. T. Bout. 1992. Immunological characterization of a 17-kDa antigen from Cryptosporidium parvum recognized early by mucosal IgA antibodies. FEMS Microbiol. Lett. 99:7-14.
46. Riggs, M. W., and L. E. Perryman. 1987. Inactivity and neutralization of Cryptosporidium parvum sporozoites. Infect. Immun. 55:2081-2087.
47. Riggs, M. W., V. A. Cama, H. L. Leary, Jr., and C. R. Sterling. 1994. Bovine antibody against Cryptosporidium parvum elicits a circumsporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect. Immun. 62:1927-1939.
48. Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147: 3149-3155.
49. Sherwood, D., K. W. Angus, D. R. Snodgrass, and S. Tzipori. 1982. Experimental cryptosporidiosis in laboratory mice. Infect. Immun. 38:471-475.
50. Soave, R. 1990. Human coccidial infections: cryptosporidiosis and isosporiasis, p. 352-358. In K. Warren and A. Mahmoud (ed.). Tropical and geographical medicine, 2nd ed. McGraw-Hill, Inc., New York, N.Y.
51. Taghi-Kilani, R., L. Sekla, and K. T. Hayglass. 1990. The role of humoral immunity in Cryptosporidium spp. infection. Studies in B cell-depleted mice. J. Immunol. 145:1571-1576.
52. Tatalick, L. M., and L. E. Perryman. 1995. Effect of surface antigen-1 (SA-1) immune lymphocyte subsets and naive cell subsets in protecting scid mice from initial and persistent infection with Cryptosporidium parvum. Vet. Immunol. Immunopathol. 47:43-55.
53. Tatalick, L. M., and L. E. Perryman. 1995. Attempts to protect severe combined immunodeficient (scid) mice with antibody enriched for reactivity to Cryptosporidium parvum surface antigen-1. Vet Parasitol. 58:281-290.
54. 52a.Theodos, C. Unpublished observation.
55. Theodos, C. M., and R. G. Titus. 1993. Salivary gland material from the sand fly Lutzomyia longipalpis has an inhibitory effect on macrophage function in vitro. Parasite Immunol. 15:481-487.
56. Titus, R. G., G. Lima, H. D. Engers, and J. A. Louis. 1984. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. J. Immunol. 133:1594-1600.
57. Tzipori, S., D. Robertson, and C. Chapman. 1986 Remission of diarrhoea due to cryptosporidiosis in an immunodeficient child treated with hyperimmune bovine colostrum. Br. Med. J. 293:1276-1277.
58. Tzipori, S., D. Robertson, D. A. Cooper, and L. White. 1987. Chronic cryptosporidial diarrhoea and hyperimmune bovine colostrum. Lancet ii:344-345.
59. Tzipori, S. 1988. Cryptosporidiosis in perspective. Adv. Parasitol. 27:63-129.
60. Tzipori, S., W. Rand, J. Griffiths, G. Widmer, and J. Crabb. 1994 Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin. Diagn. Lab. Immunol. 1:450-463.
61. Tzipori, S., W. Rand, and C. M. Theodos. 1995. Evaluation of a two-phase scid model preconditioned with anti-interferon-γ monoclonal antibody for drug testing against Cryptosporidium parvum. J. Infect. Dis. 172:1160-1164
62. Ungar, B. L. P., J. A. Burris, C. A. Quinn, and F. D. inkelman. 1990. New mouse models for chronic Cryptosporidium infection in immunodeficient hosts. Infect. Immun. 58:961-969.
63. Ungar, B. L. P., D. J. Ward, R. Fayer, and C. A. Quinn. 1990 Cessation of Cryptosporidium-associated diarrhea in an acquired immune deficiency syndrome patient after treatment with hyperimmune bovine colostrum. Gastroenterology 98:486-489.
64. + T lymphocytes in protective immunity. J. Immunol. 147:1014-1022.
65. Urban, J. F., R. Fayer, S.-J. Chen, W. C. Gause, M. K. Gately, and F. Finkelman. 1996. 11.-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum. J Immunol. 156:263-268.
66. + effector cells default to the TH2 pathway in interferon γ-deficient mice with Letshmania major. 3. Exp. Med. 179:1367-1371.
67. Waters, W. R., and J. A. Harp. 1996. Cryptosporidium parvum infection in T-cell receptor (TCR)-α- and TCR-γ-deficient mice. Infect. Immun. 64: 1854-1857.
68. Whitmire, W., and J. Harp. 1990. In vitro murine lymphocyte blastogenic responses to Cryptosporidium parvum. 3. Parasitol. 76:450-452.
69. Wilson, M. 1991. A world guide to infectious diseases, distribution and diagnosis, p. 476-477. Oxford University Press. Inc., New York. N.Y.